- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04725708
Cognitive Functions on Coronary Surgery
The Effect of Intraoperative Arterial Oxygen Levels on Cognitive Functions After Coronary Bypass Graft Surgery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In most cardiovascular surgeries, patients are frequently followed up at hyperoxemic level for safety purposes against the risk of tissue hypoxia that may develop during surgery due to CPB use. At the level of hyperoxemia, there are opinions that the ischemia-reperfusion damage increases with the follow-up of CABG surgery, microcirculation is impaired and tissue oxygenation is impaired due to the resulting hyperoxemic vasoconstriction. Recent research has focused on evaluating optimal oxygen levels in CPB during cardiac surgery. However, the potential of tightly regulated intraoperative normoxia to improve POCD following cardiac surgery has not been studied prospectively.
The purpose of this study is to determine whether patients who underwent CPB and CABG, which were preserved under normoxic conditions during the intraoperative period, would have a lower incidence of early and late POCD than those exposed to hyperoxia.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bursa, Turkey, 16200
- Bursa YIERH
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- adult patients scheduled to undergo elective cardiopulmonary bypass graft surgery
Exclusion Criteria:
- severe preoperative cognitive impairment(i.e. dementia, intellectual disorder)
- Non-Turkish speaking patients
- presence of end-stage organ failure
- patients requiring emergency coronary surgery
- surgical procedures requiring single lung ventilation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: normoxy
Group 1(n=50) FiO2%40, PaO2<180 ve PaO2≥80mmHg MMSE will be applied to patients before surgery. At the determined measurement times body and blood temperature, SpO2, HR, MAP, PH, blood gas lactate, blood gas base deficit, urine output, PaO2, PaCO2, Htc, FiO2, right and left rSO2 values were monitored. An rSO2 less than 45% triggered an alarm, the anesthesiologist timed the event, and after 60 seconds initiated an intervention protocol means; PaO2 levels were checked, PaO2> 100 mmHg was achieved, if not improved, pump blood flow, mean arterial pressure were increased, if there is still no response and hematocrit <20%, patients were scheduled for erythrocyte transfusion until the rSO2 was restored to at least 60% at both probes.In the postoperative period, at the 24th hour, when routine cardiological controls were performed 1., 3., 6. Simultaneous MMSE will be repeated in months. |
During the surgery, cerebral oxygenation will be followed and intervention will be made to pH, PaO2, PaCO2, mean arterial pressure, hematocrit when necessary.
In addition perfusion flow was maintained at or close to between 2.2-2.5 L/min/m2 .
Perfusion pressure was adjusted using a phenylephrine infusion to maintain a mean arterial pressure of 50 to 70 mm Hg.
|
Experimental: hyperoxia
Group 2(n=50) FiO2%100, PaO2≥180mmHg MMSE will be applied to patients before surgery.
At the determined measurement times body and blood temperature, SpO2, HR, MAP, PH, blood gas lactate, blood gas base deficit, urine output, PaO2, PaCO2, Htc, FiO2, right and left rSO2 values were monitored..In the postoperative period, at the 24th hour, when routine cardiological controls were performed 1., 3., 6. Simultaneous MMSE will be repeated in months.
|
During the surgery, cerebral oxygenation will be followed and intervention will be made to pH, PaO2, PaCO2, mean arterial pressure, hematocrit when necessary.
In addition perfusion flow was maintained at or close to between 2.2-2.5 L/min/m2 .
Perfusion pressure was adjusted using a phenylephrine infusion to maintain a mean arterial pressure of 50 to 70 mm Hg.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
postoperative neurocognitive function
Time Frame: 12 hours after surgery
|
Change on MMSE is important for neurocognitive disorder.The MMSE consists of cognitive functions of orientation, attention, calculation, memory and language.
|
12 hours after surgery
|
postoperative neurocognitive function
Time Frame: 24 hours after surgery
|
Change on MMSE is important for neurocognitive disorder.The MMSE consists of cognitive functions of orientation, attention, calculation, memory and language.
|
24 hours after surgery
|
postoperative neurocognitive function
Time Frame: 1 month after surgery
|
Change on MMSE is important for neurocognitive disorder.The MMSE consists of cognitive functions of orientation, attention, calculation, memory and language.
|
1 month after surgery
|
postoperative neurocognitive function
Time Frame: 3 months after surgery
|
Change on MMSE is important for neurocognitive disorder.The MMSE consists of cognitive functions of orientation, attention, calculation, memory and language.
|
3 months after surgery
|
postoperative neurocognitive function
Time Frame: 6 months after surgery
|
Change on MMSE is important for neurocognitive disorder.The MMSE consists of cognitive functions of orientation, attention, calculation, memory and language.
|
6 months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Extubation time after surgery
Time Frame: During the hospitalization for postoperative recovery ,average 8 days
|
Weaning times from mechanical ventilation among patients who are followed up with the same intensive care approach after surgery
|
During the hospitalization for postoperative recovery ,average 8 days
|
Collaborators and Investigators
Investigators
- Study Chair: Halil Erkan H SAYAN, MD, Bursa Yüksek İhtisas Education and Research Hospital
- Study Chair: Filiz F ATA, MD, Bursa Yüksek İhtisas Education and Research Hospital
- Study Chair: Canan C YILMAZ, MD, Bursa Yüksek İhtisas Education and Research Hospital
- Study Chair: Ayşe Neslihan AN BALKAYA, MD, Bursa Yüksek İhtisas Education and Research Hospital
- Study Chair: Cüneyt C ERİŞ, Bursa Yüksek İhtisas Education and Research Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Bursa YIERH
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neurocognitive Disorders
-
Jinan Central HospitalRecruitingPerioperative Neurocognitive DysfunctionChina
-
Centre Hospitalier Universitaire de la RéunionRecruiting
-
Qianfoshan HospitalNot yet recruitingFrail Elderly | Perioperative Neurocognitive Disorders
-
Universidad de MurciaCompletedNeurocognitive Disorder, Etiology of Neurocognitive DisorderSpain
-
Xijing HospitalNot yet recruitingPerioperative Neurocognitive Disorders
-
UMC UtrechtGilead SciencesCompletedHIV Associated Neurocognitive Disorder | Neurocognitive DeclineNetherlands
-
Posit Science CorporationCompletedHIV-associated Neurocognitive DysfunctionUnited States
-
Charite University, Berlin, GermanyCompletedNeurocognitive DysfunctionGermany
-
Duke UniversityPfizerWithdrawnNeurocognitive DysfunctionUnited States
-
First Affiliated Hospital Xi'an Jiaotong UniversityLanZhou University; Tongji Hospital; The First Affiliated Hospital of Zhengzhou... and other collaboratorsRecruitingPostoperative Neurocognitive DisordersChina
Clinical Trials on procedure: cerebral oxygenation intervention
-
University of MichiganCompleted
-
Dr. Gordon BoydRecruitingDelirium | Critical Illness | Cognitive Impairment | Acute Kidney Injury | Cerebral Oxygenation | Cerebral AutoregulationCanada
-
Centro Hospitalar do Tâmega e SousaTerminated
-
Nationwide Children's HospitalCompletedTransfusion Reaction | Idiopathic ScoliosisUnited States
-
Universitaire Ziekenhuizen KU LeuvenCompletedHeart Defects, CongenitalBelgium
-
Medical University of GrazRigshospitalet, DenmarkCompletedGeneral Movement AssessmentAustria
-
King Faisal UniversityCompleted
-
Icahn School of Medicine at Mount SinaiCompleted
-
Medical University of GrazRecruitingBlood Pressure | Cerebral Tissue OxygenationAustria
-
IWK Health CentreRecruitingPreterm InfantCanada